New drugs target C.diff superbug

19 September 2017
Presented by Chris Smith.

C. diff - or Clostridium difficile - is a superbug that can cause major problems in hospitals. It leads to life-threatening diarrhoea and intestinal inflammation in patients who catch it, it spreads easily, and patients who do recover often relapse many times afterwards because the spectrum of so-called “good bacteria” in the bowel also goes off-kilter when you treat the infection. What’s needed are highly-targeted antibiotics that can hit exclusively C. diff and not affect the good bacteria that we need to keep us healthy. Luckily, Sheffield University’s Joe Kirk is on the case...

Add a comment